Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 1/20 | 0.36 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.33 |
| ▸ | CCR2 | P41597 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.32 |
| ▸ | PER2 | O15055 | 1/20 | 0.32 |
| ▸ | CRY1 | Q16526 | 1/20 | 0.32 |
| ▸ | CRY2 | Q49AN0 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28443035 | 0.98 | P2RX7 (0.35) | P2RX7CTDSP1CCR2CYP1A2KDM4E | |
| SCHEMBL129825 | 0.83 | P2RX7 (0.34) | P2RX7CTDSP1CCR2CYP1A2KDM4E | |
| SCHEMBL31067927 | 0.76 | P2RX7 (0.35) | P2RX7CTDSP1CCR2CYP1A2KDM4E | |
| SCHEMBL361395 | 0.73 | KMT2A (0.47) | P2RX7CYP1A2ALDH1A1MAPTHTT | |
| SCHEMBL9255278 | 0.72 | CYP1A2 (0.46) | P2RX7CTDSP1CYP1A2KDM4EALOX12 | |
| SCHEMBL30225243 | 0.72 | ALDH1A1 (0.42) | P2RX7CTDSP1CYP1A2ALDH1A1L3MBTL1 | |
| SCHEMBL30226513 | 0.72 | ALDH1A1 (0.42) | P2RX7CTDSP1CYP1A2ALDH1A1L3MBTL1 | |
| SCHEMBL7058599 | 0.71 | CYP1A2 (0.33) | P2RX7CTDSP1CCR2CYP1A2NAPRT | |
| SCHEMBL31092422 | 0.71 | — | — | |
| SCHEMBL31151688 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023239822-A1 | CO-AGENTS AS THERAPY AGAINST ANAEROBIC PATHOGENS | FLEURIR ABX LLC (US) | 2023-12-14 | — | — | WO | claimed |
| EP-1899404-B1 | A CHAIN-END FUNCTIONALIZED POLY(ETHYLENE OXIDE) AND PROCESS FOR THE PREPARATION OF A NANO-SIZED TRANSITION METAL OR METAL SALT USING THE SAME | YOUL CHON CHEMICAL CO LTD (KR) | 2020-11-04 | — | — | EP | claimed |
| CN-106124659-A | The method of prediction sulfa antibiotics rate of photocatalytic oxidation | 井冈山大学 | 2016-11-16 | — | — | CN | claimed |
| EP-2150568-B1 | CHAIN-END FUNCTIONALIZED METHOXY POLY(ETHYLENE GLYCOL)AND METAL NANO-PARTICLES USING THE SAME | YOUL CHON CHEMICAL CO LTD (KR) | 2016-03-23 | — | — | EP | claimed |
| US-9005583-B2 | Chain-end functionalized poly(ethykene oxide) and process for the preparation of a nano-sized transition metal or metal salt using the same | YOUL CHON CHEMICAL CO., LTD. (KR) | 2015-04-14 | — | — | US | claimed |
| JP-2010528172-A | — | — | 2010-08-19 | — | — | JP | claimed |
| US-20100172996-A1 | Chain-End Functionalized Methoxy Poly(Ethylene Glycol) and Metal Nano-Particles Using the Same | YOUL CHON CHEMICAL CO., LTD. (KR) | 2010-07-08 | — | — | US | claimed |
| EP-2150568-A1 | CHAIN-END FUNCTIONALIZED METHOXY POLY(ETHYLENE GLYCOL)AND METAL NANO-PARTICLES USING THE SAME | Youl Chon Chemical Co. Ltd. (KR) | 2010-02-10 | — | — | EP | claimed |
| EP-1899404-A4 | A CHAIN-END FUNCTIONALIZED POLY(ETHYLENE OXIDE) AND PROCESS FOR THE PREPARATION OF A NANO-SIZED TRANSITION METAL OR METAL SALT USING THE SAME | YOUL CHON CHEMICAL CO LTD (KR) | 2009-09-09 | — | — | EP | claimed |
| US-20090142268-A1 | CHAIN-END FUNCTIONALIZED POLY(ETHYKENE OXIDE) AND PROCESS FOR THE PREPARATION OF A NANO-SIZED TRANSITION METAL OR METAL SALT USING THE SAME | YOUL CHON CHEMICAL CO., LTD. (KR) | 2009-06-04 | — | — | US | claimed |
| JP-2009500488-A | — | — | 2009-01-08 | — | — | JP | claimed |
| WO-2008147128-A1 | CHAIN-END FUNCTIONALIZED METHOXY POLY(ETHYLENE GLYCOL)AND METAL NANO-PARTICLES USING THE SAME | YOUL CHON CHEMICAL CO., LTD. (KR) | 2008-12-04 | — | — | WO | claimed |
| EP-1899404-A1 | A CHAIN-END FUNCTIONALIZED POLY(ETHYLENE OXIDE) AND PROCESS FOR THE PREPARATION OF A NANO-SIZED TRANSITION METAL OR METAL SALT USING THE SAME | Youl Chon Chemical Co. Ltd. (KR) | 2008-03-19 | — | — | EP | claimed |
| WO-2007007976-A1 | A CHAIN-END FUNCTIONALIZED POLY(ETHYLENE OXIDE) AND PROCESS FOR THE PREPARATION OF A NANO-SIZED TRANSITION METAL OR METAL SALT USING THE SAME | YOUL CHON CHEMICAL CO., LTD. (KR) | 2007-01-18 | — | — | WO | claimed |
| US-20070009592-A1 | IMMEDIATE RELEASE PHARMACEUTICAL GRANULE COMPOSITIONS AND A CONTINUOUS PROCESS FOR MAKING THEM | UNIVERSITEIT GENT (BE) | 2007-01-11 | — | — | US | claimed |
| EP-0255100-A2 | Use of trimetrexate and its salts for the preparation of pharmaceutical compositions for treating infections of the mycobacterium-avium-intracellulare complex | WARNER-LAMBERT COMPANY (US) | 1988-02-03 | — | — | EP | claimed |
| US-4661340-A | Quail egg based stabilized foam compositions for cosmetic purposes | INTERKEMIA VEGYIPARI GAZDASAGI TARSASAG (HU) | 1987-04-28 | — | — | US | claimed |
| US-4532245-A | Pharmaceutical compositions | HOFFMANN-LA ROCHE INC. (US) | 1985-07-30 | — | — | US | claimed |
| US-4082842-A | SULFONYLUREA-TYPE HYPOGLYCEMIC, ASCORBIC ACID, SULFAMETHOXYPYRIDAZINE | NAHLE ARMANDO | 1978-04-04 | — | — | US | claimed |
| EP-3220920-B1 | COMBINATION THERAPY EFFECTIVE AGAINST MICROORGANISMS, INCLUDING DRUG RESISTANT MICROORGANISMS | FLEURIR ABX LLC (US) | 2025-06-04 | — | — | EP | disclosed |
| CN-120022878-A | Amphiphilic covalent organic framework mixed mode chromatographic stationary phase and preparation method and application thereof | 河南工业大学 | 2025-05-23 | — | — | CN | disclosed |
| EP-4536217-A1 | CO-AGENTS AS THERAPY AGAINST ANAEROBIC PATHOGENS | Fleurir Abx LLC (US) | 2025-04-16 | — | — | EP | disclosed |
| CN-118750586-A | Collagen-based pharmaceutical compositions and devices and methods of manufacture and use thereof | 莎思坦控股有限责任公司 | 2024-10-11 | — | — | CN | disclosed |
| CN-118750585-A | Collagen-based pharmaceutical compositions and devices and methods of manufacture and use thereof | 莎思坦控股有限责任公司 | 2024-10-11 | — | — | CN | disclosed |
| CN-118717953-A | Collagen-based pharmaceutical compositions and devices and methods of manufacture and use thereof | 莎思坦控股有限责任公司 | 2024-10-01 | — | — | CN | disclosed |
| US-20240293434-A1 | COMBINATION THERAPY EFFECTIVE AGAINST MICROORGANISMS, INCLUDING DRUG RESISTANT MICROORGANISMS | FLEURIR ABX LLC (US) | 2024-09-05 | — | — | US | disclosed |
| US-11925653-B2 | Combination therapy effective against microorganisms, including drug resistant microorganisms | FLEURIR ABX, LLC (US) | 2024-03-12 | — | — | US | disclosed |
| CN-117330743-A | Method for rapidly detecting toxicity of mixture of microplastic and antibiotic by using scenedesmus obliquus | 桂林理工大学 | 2024-01-02 | — | — | CN | disclosed |
| WO-2023239822-A1 | CO-AGENTS AS THERAPY AGAINST ANAEROBIC PATHOGENS | FLEURIR ABX LLC (US) | 2023-12-14 | — | — | WO | disclosed |
| US-20230398101-A1 | Co-agents as Therapy Against Anaerobic Pathogens | FLEURIR ABX LLC (US) | 2023-12-14 | — | — | US | disclosed |
| CN-117092266-A | Method for detecting sulfonamide veterinary drug residue mixed solution sample in methanol | 青岛博栋检测服务有限公司 | 2023-11-21 | — | — | CN | disclosed |
| CN-116200393-A | Mixed broad-spectrum nucleic acid aptamer for simultaneously detecting 9 sulfonamide drugs | 福州大学 | 2023-06-02 | — | — | CN | disclosed |
| CN-111848834-B | Application of cationic polymer modified by fluorine-containing compound in preparing medicine for transmucosal administration | 苏州大学 | 2023-01-24 | — | — | CN | disclosed |
| US-20220233557-A1 | Combination Therapy Effective Against Microorganisms, Including Drug Resistant Microorganisms | FLEURIR ABX LLC (US) | 2022-07-28 | — | — | US | disclosed |
| CN-111604030-B | Graphene oxide-covalent organic framework material composite material, capillary electrochromatography column and preparation method | 首都师范大学 | 2022-03-22 | — | — | CN | disclosed |
| CN-110618224-B | [ H ]2Nmim][NTf2]@ UiO-66-Br nano composite material and application thereof | 华东师范大学 | 2021-11-19 | — | — | CN | disclosed |
| US-10898501-B2 | Combination therapy effective against microorganisms, including drug resistant microorganisms | FLEURIR ABX, LLC (US) | 2021-01-26 | — | — | US | disclosed |
| CN-112051345-A | High performance liquid chromatography detection method for sulfonamides in raw fresh milk | 河南省奶牛生产性能测定有限公司 | 2020-12-08 | — | — | CN | disclosed |
| EP-1899404-B1 | A CHAIN-END FUNCTIONALIZED POLY(ETHYLENE OXIDE) AND PROCESS FOR THE PREPARATION OF A NANO-SIZED TRANSITION METAL OR METAL SALT USING THE SAME | YOUL CHON CHEMICAL CO LTD (KR) | 2020-11-04 | — | — | EP | disclosed |
| CN-111848834-A | Application of cationic polymer modified by fluorine-containing compound in preparing transmucosal drug delivery of drug | 苏州大学 | 2020-10-30 | — | — | CN | disclosed |
| CN-111848832-A | Application of fluorine-containing compound modified cationic polymer as drug carrier and preparation method thereof | 苏州大学 | 2020-10-30 | — | — | CN | disclosed |
| CN-111604030-A | Graphene oxide-covalent organic framework material composite material, capillary electrochromatography column and preparation method | 首都师范大学 | 2020-09-01 | — | — | CN | disclosed |
| CN-110618224-A | [ H ]2Nmim][NTf2]@ UiO-66-Br nano composite material and application thereof | 华东师范大学 | 2019-12-27 | — | — | CN | disclosed |
| CN-110179806-A | Sulfa drugs application in preparation of anti-tumor drugs | 首都医科大学 | 2019-08-30 | — | — | CN | disclosed |
| US-20180369259-A1 | COMBINATION THERAPY EFFECTIVE AGAINST MICROORGANISMS, INCLUDING DRUG RESISTANT MICROORGANISMS | FLEURIR ABX LLC (US) | 2018-12-27 | — | — | US | disclosed |
| CN-108490088-A | A kind of detection method of the animal derived product residue of veterinary drug of detection | 汕头出入境检验检疫局检验检疫技术中心 | 2018-09-04 | — | — | CN | disclosed |
| EP-3220920-A1 | COMBINATION THERAPY EFFECTIVE AGAINST MICROORGANISMS, INCLUDING DRUG RESISTANT MICROORGANISMS | Fleurir Abx LLC (US) | 2017-09-27 | — | — | EP | disclosed |
| CN-106124659-A | The method of prediction sulfa antibiotics rate of photocatalytic oxidation | 井冈山大学 | 2016-11-16 | — | — | CN | disclosed |
| WO-2016081592-A1 | COMBINATION THERAPY EFFECTIVE AGAINST MICROORGANISMS, INCLUDING DRUG RESISTANT MICROORGANISMS | FLEURIR ABX LLC (US) | 2016-05-26 | — | — | WO | disclosed |
| EP-2150568-B1 | CHAIN-END FUNCTIONALIZED METHOXY POLY(ETHYLENE GLYCOL)AND METAL NANO-PARTICLES USING THE SAME | YOUL CHON CHEMICAL CO LTD (KR) | 2016-03-23 | — | — | EP | disclosed |
| CN-104084176-B | Rich water chromatographic stationary phases of a kind of silver nano-grain-lactose bonded silica gel and preparation method thereof | COMPREHENSIVE INSPECTION AND QUARANTINE TECHNOLOGY CENTER, ZHENJIANG ENTRY-EXIT INSPECTION AND QUARANTINE BUREAU (CN) | 2016-02-17 | — | — | CN | disclosed |
| CN-104028253-B | A kind of gold nano grain-polysaccharide bonded silica gel stationary phase and preparation method thereof | COMPREHENSIVE INSPECTION AND QUARANTINE TECHNOLOGY CENTER, ZHENJIANG ENTRY-EXIT INSPECTION AND QUARANTINE BUREAU (CN) | 2015-10-28 | — | — | CN | disclosed |
| US-9005583-B2 | Chain-end functionalized poly(ethykene oxide) and process for the preparation of a nano-sized transition metal or metal salt using the same | YOUL CHON CHEMICAL CO., LTD. (KR) | 2015-04-14 | — | — | US | disclosed |
| CN-104084176-A | Silver nanoparticle-lactose bonded silica gel stationary phase for Per aqueous chromatography, and preparation method thereof | INSPECTION AND QUARANTINE COMPREHENSIVE TECHNOLOGY CT OF ZHENJIANG ENTRY EXIT INSPECTION AND QUARANT | 2014-10-08 | — | — | CN | disclosed |
| CN-104028253-A | Gold nanoparticle-polysaccharide bonded silica gel fixed phase and preparation method thereof | INSPECTION AND QUARANTINE COMPREHENSIVE TECHNOLOGY CT OF ZHENJIANG ENTRY EXIT INSPECTION AND QUARANT | 2014-09-10 | — | — | CN | disclosed |
| US-8349366-B2 | Immediate release pharmaceutical granule compositions and a continuous process for making them | UNIVERSITEIT GENT (BE) | 2013-01-08 | — | — | US | disclosed |
| US-8337897-B2 | Immediate release pharmaceutical granule compositions and a continuous process for making them | UNIVERSITEIT GENT (BE) | 2012-12-25 | — | — | US | disclosed |
| US-8258137-B2 | Process for release of biologically active species from mesoporous oxide systems | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2012-09-04 | — | — | US | disclosed |
| US-20110027377-A1 | IMMEDIATE RELEASE PHARMACEUTICAL GRANULE COMPOSITIONS AND A CONTINUOUS PROCESS FOR MAKING THEM | UNIVERSITEIT GENT (BE) | 2011-02-03 | — | — | US | disclosed |
| US-20110008454-A1 | IMMEDIATE RELEASE PHARMACEUTICAL GRANULE COMPOSITIONS AND A CONTINUOUS PROCESS FOR MAKING THEM | UNIVERSITEIT GENT (BE) | 2011-01-13 | — | — | US | disclosed |
| US-20100172996-A1 | Chain-End Functionalized Methoxy Poly(Ethylene Glycol) and Metal Nano-Particles Using the Same | YOUL CHON CHEMICAL CO., LTD. (KR) | 2010-07-08 | — | — | US | disclosed |
| EP-2150568-A1 | CHAIN-END FUNCTIONALIZED METHOXY POLY(ETHYLENE GLYCOL)AND METAL NANO-PARTICLES USING THE SAME | Youl Chon Chemical Co. Ltd. (KR) | 2010-02-10 | — | — | EP | disclosed |
| EP-1899404-A4 | A CHAIN-END FUNCTIONALIZED POLY(ETHYLENE OXIDE) AND PROCESS FOR THE PREPARATION OF A NANO-SIZED TRANSITION METAL OR METAL SALT USING THE SAME | YOUL CHON CHEMICAL CO LTD (KR) | 2009-09-09 | — | — | EP | disclosed |
| US-20090192205-A1 | PROCESS FOR RELEASE OF BIOLOGICALLY ACTIVE SPECIES | KATHOLIEKE UNIVERSITEIT LEUVEN K.U. LEUVEN R&D (BE) | 2009-07-30 | — | — | US | disclosed |
| US-20090142268-A1 | CHAIN-END FUNCTIONALIZED POLY(ETHYKENE OXIDE) AND PROCESS FOR THE PREPARATION OF A NANO-SIZED TRANSITION METAL OR METAL SALT USING THE SAME | YOUL CHON CHEMICAL CO., LTD. (KR) | 2009-06-04 | — | — | US | disclosed |
| WO-2008147128-A1 | CHAIN-END FUNCTIONALIZED METHOXY POLY(ETHYLENE GLYCOL)AND METAL NANO-PARTICLES USING THE SAME | YOUL CHON CHEMICAL CO., LTD. (KR) | 2008-12-04 | — | — | WO | disclosed |
| EP-1899404-A1 | A CHAIN-END FUNCTIONALIZED POLY(ETHYLENE OXIDE) AND PROCESS FOR THE PREPARATION OF A NANO-SIZED TRANSITION METAL OR METAL SALT USING THE SAME | Youl Chon Chemical Co. Ltd. (KR) | 2008-03-19 | — | — | EP | disclosed |
| WO-2007007976-A1 | A CHAIN-END FUNCTIONALIZED POLY(ETHYLENE OXIDE) AND PROCESS FOR THE PREPARATION OF A NANO-SIZED TRANSITION METAL OR METAL SALT USING THE SAME | YOUL CHON CHEMICAL CO., LTD. (KR) | 2007-01-18 | — | — | WO | disclosed |
| US-20070009592-A1 | IMMEDIATE RELEASE PHARMACEUTICAL GRANULE COMPOSITIONS AND A CONTINUOUS PROCESS FOR MAKING THEM | UNIVERSITEIT GENT (BE) | 2007-01-11 | — | — | US | disclosed |
| US-20050058705-A1 | Immediate release pharmaceutical granule compositions and a continuous process for making them | UNIVERSITEIT GENT (BE) | 2005-03-17 | — | — | US | disclosed |
| US-6476063-B2 | DEVOID OF CENTRAL NERVOUS SYSTEM EFFECTS; TOPICAL AND SYSTEMIC ADMINISTRATION; ANTIPRURITIC AGEENTS; ANALGESICS 1-ARYLMETHYLCARBONYL-2-PYRROLIDIN-1-YL-PIPERAZINES | ADOLOR CORPORATION | 2002-11-05 | — | — | US | disclosed |
| US-6114330-A | BACTERICIDES | HOFFMANN-LA ROCHE INC. (US) | 2000-09-05 | — | — | US | disclosed |
| US-4888327-A | EYE INFECTIONS | ALCON LABORATORIES, INC. (US) | 1989-12-19 | — | — | US | disclosed |
| US-4532245-A | Pharmaceutical compositions | HOFFMANN-LA ROCHE INC. (US) | 1985-07-30 | — | — | US | disclosed |
| US-4332796-A | MICROCRYSTALS COATED WITH MIXTURES OF PHOSPHOLIPIDS AND NONIONIC SURFACTANTS | LABORATORIOS BAGO S.A. (AR) | 1982-06-01 | — | — | US | disclosed |
| US-4211776-A | ANTIEMETICS | CHOAY S.A. (FR) | 1980-07-08 | — | — | US | disclosed |
| EP-0000336-A1 | N-benzylpyrimidinyl-amidines, process for their preparation and medicines containing them | BASF Aktiengesellschaft (DE) | 1979-01-24 | — | — | EP | disclosed |
| US-4132786-A | ANTIEMETICS, ANTICONVULSANTS, ANESTHETICS, ANTIBIOTICS | MOREAU ROBERT C | 1979-01-02 | — | — | US | disclosed |
| US-4082842-A | SULFONYLUREA-TYPE HYPOGLYCEMIC, ASCORBIC ACID, SULFAMETHOXYPYRIDAZINE | NAHLE ARMANDO | 1978-04-04 | — | — | US | disclosed |
| US-4082842-A | SULFONYLUREA-TYPE HYPOGLYCEMIC, ASCORBIC ACID, SULFAMETHOXYPYRIDAZINE | NAHLE ARMANDO | 1978-04-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100172996-A1 | Chain-End Functionalized Methoxy Poly(Ethylene Glycol) and Metal Nano-Particles Using the Same | MPEG1, MLEC, MSN | P2RX7 4864/4885CTDSP1 529/4885CCR2 2747/4885 |
| US-20090142268-A1 | CHAIN-END FUNCTIONALIZED POLY(ETHYKENE OXIDE) AND PROCESS FOR THE PREPARATION OF A NANO-SIZED TRANSITION METAL OR METAL SALT USING THE SAME | SIK1, PROC, POLK | P2RX7 4812/4885CTDSP1 410/4885CCR2 3610/4885 |
| US-20240293434-A1 | COMBINATION THERAPY EFFECTIVE AGAINST MICROORGANISMS, INCLUDING DRUG RESISTANT MICROORGANISMS | SLC11A2, MYD88, FPR2 | P2RX7 1286/4885CTDSP1 4345/4885CCR2 273/4885 |
| US-11925653-B2 | Combination therapy effective against microorganisms, including drug resistant microorganisms | SLC11A2, ABCC1, DDT | P2RX7 1099/4885CTDSP1 4695/4885CCR2 225/4885 |
| US-20220233557-A1 | Combination Therapy Effective Against Microorganisms, Including Drug Resistant Microorganisms | SLC11A2, ABCC1, DDT | P2RX7 1099/4885CTDSP1 4695/4885CCR2 225/4885 |
| US-20180369259-A1 | COMBINATION THERAPY EFFECTIVE AGAINST MICROORGANISMS, INCLUDING DRUG RESISTANT MICROORGANISMS | SLC11A2, ABCC1, DDT | P2RX7 1099/4885CTDSP1 4695/4885CCR2 225/4885 |
| US-10898501-B2 | Combination therapy effective against microorganisms, including drug resistant microorganisms | SLC11A2, ABCC1, DDT | P2RX7 1099/4885CTDSP1 4695/4885CCR2 225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.